Fig. 2.
Fig. 2. Percentage of HSC, FC, and CD8+ T cells in PB during treatment with (A) FL alone (n = 5), (B) G-CSF alone (n = 5), or (C) FL + G-CSF (n = 5). FL (10 μg/mouse) was injected SC from day 1 to 10 and G-CSF (7.5 μg/mouse) from day 4 to 10. PB was stained for HSC (▪) (lineage−/Sca-1+/c-kit+), FC (□) (CD8+/βTCR−/γδTCR−), and CD8+ T cells (▧) (CD8+/βTCR+). Results show the mean (SEM) percentage before and on day 7 and day 10 of growth factor administration. Percentages of HSC, FC, or CD8+ T cells that differed significantly from day 0 values are marked (* P< .05; ** P < .005; or *** P < .0005).

Percentage of HSC, FC, and CD8+ T cells in PB during treatment with (A) FL alone (n = 5), (B) G-CSF alone (n = 5), or (C) FL + G-CSF (n = 5). FL (10 μg/mouse) was injected SC from day 1 to 10 and G-CSF (7.5 μg/mouse) from day 4 to 10. PB was stained for HSC (▪) (lineage/Sca-1+/c-kit+), FC (□) (CD8+/βTCR/γδTCR), and CD8+ T cells (▧) (CD8+/βTCR+). Results show the mean (SEM) percentage before and on day 7 and day 10 of growth factor administration. Percentages of HSC, FC, or CD8+ T cells that differed significantly from day 0 values are marked (* P< .05; ** P < .005; or *** P < .0005).

Close Modal

or Create an Account

Close Modal
Close Modal